Document is current
Any future updates will be listed below
-
Authors
Friedlander, David F. https://orcid.org/0000-0002-3644-3511
Krimphove, Marieke J.
Cole, Alexander P.
Tully, Karl H.
Lipsitz, Stuart R.
Kibel, Adam S.
Kilbridge, Kerry L.
Trinh, Quoc-Dien
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (2T32DK007527-33)
- License Information
-
More Information
Article History
Received: 5 April 2019
First Online: 17 December 2019
Disclosure
: The National Cancer Data Base (NCDB) is a joint project of the Commission on Cancer (CoC) of the American College of Surgeons and the American Cancer Society. The CoC’s NCDB and the hospitals participating in the CoC NCDB are the source of de-identified data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors. Quoc-Dien Trinh had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
: Quoc-Dien Trinh reports personal fees from Astellas, Bayer, Janssen, Insightec and Intuitive Surgical. Adam S. Kibel reports personal fees from Profound, Insightec, Janssen, Pfizer, Merck, Blue Earth, and Bristol-Myers Squibb.
